<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>46</viewCount><searchCount>0</searchCount></scores><additional><submitter>Sondergaard MT</submitter><funding>Alberta Innovates</funding><funding>Novo Nordisk</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><funding>Lundbeckfonden</funding><funding>Novo Nordisk Fonden</funding><funding>Lundbeck Foundation</funding><funding>NIGMS NIH HHS</funding><funding>CIHR</funding><funding>Det Frie Forskningsråd</funding><pagination>1385-1395</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5270481</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>292(4)</volume><pubmed_abstract>A number of point mutations in the intracellular Ca&lt;sup>2+&lt;/sup>-sensing protein calmodulin (CaM) are arrhythmogenic, yet their underlying mechanisms are not clear. These mutations generally decrease Ca&lt;sup>2+&lt;/sup> binding to CaM and impair inhibition of CaM-regulated Ca&lt;sup>2+&lt;/sup> channels like the cardiac Ca&lt;sup>2+&lt;/sup> release channel (ryanodine receptor, RyR2), and it appears that attenuated CaM Ca&lt;sup>2+&lt;/sup> binding correlates with impaired CaM-dependent RyR2 inhibition. Here, we investigated the RyR2 inhibitory action of the CaM p.Phe142Leu mutation (F142L; numbered including the start-Met), which markedly reduces CaM Ca&lt;sup>2+&lt;/sup> binding. Surprisingly, CaM-F142L had little to no aberrant effect on RyR2-mediated store overload-induced Ca&lt;sup>2+&lt;/sup> release in HEK293 cells compared with CaM-WT. Furthermore, CaM-F142L enhanced CaM-dependent RyR2 inhibition at the single channel level compared with CaM-WT. This is in stark contrast to the actions of arrhythmogenic CaM mutations N54I, D96V, N98S, and D130G, which all diminish CaM-dependent RyR2 inhibition. Thermodynamic analysis showed that apoCaM-F142L converts an endothermal interaction between CaM and the CaM-binding domain (CaMBD) of RyR2 into an exothermal one. Moreover, NMR spectra revealed that the CaM-F142L-CaMBD interaction is structurally different from that of CaM-WT at low Ca&lt;sup>2+&lt;/sup> These data indicate a distinct interaction between CaM-F142L and the RyR2 CaMBD, which may explain the stronger CaM-dependent RyR2 inhibition by CaM-F142L, despite its reduced Ca&lt;sup>2+&lt;/sup> binding. Collectively, these results add to our understanding of CaM-dependent regulation of RyR2 as well as the mechanistic effects of arrhythmogenic CaM mutations. The unique properties of the CaM-F142L mutation may provide novel clues on how to suppress excessive RyR2 Ca&lt;sup>2+&lt;/sup> release by manipulating the CaM-RyR2 interaction.</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>The Arrhythmogenic Calmodulin p.Phe142Leu Mutation Impairs C-domain Ca2+ Binding but Not Calmodulin-dependent Inhibition of the Cardiac Ryanodine Receptor.</pubmed_title><pmcid>PMC5270481</pmcid><funding_grant_id>2013–14432</funding_grant_id><funding_grant_id>HL057832</funding_grant_id><funding_grant_id>DFF-4093–00242</funding_grant_id><funding_grant_id>DFF-4181–00447</funding_grant_id><funding_grant_id>NNF15OC0017762</funding_grant_id><funding_grant_id>R01 HL057832</funding_grant_id><funding_grant_id>AR054098</funding_grant_id><funding_grant_id>201400104</funding_grant_id><funding_grant_id>NNF16OC0023344</funding_grant_id><funding_grant_id>R151-2013-14432</funding_grant_id><funding_grant_id>R01 GM111397</funding_grant_id><funding_grant_id>NNF15OC001776299</funding_grant_id><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Larsen KT</pubmed_authors><pubmed_authors>Wang R</pubmed_authors><pubmed_authors>Wimmer R</pubmed_authors><pubmed_authors>Van Petegem F</pubmed_authors><pubmed_authors>Tian X</pubmed_authors><pubmed_authors>Holt C</pubmed_authors><pubmed_authors>Chen SR</pubmed_authors><pubmed_authors>Sondergaard MT</pubmed_authors><pubmed_authors>Nani A</pubmed_authors><pubmed_authors>Fill M</pubmed_authors><pubmed_authors>Overgaard MT</pubmed_authors><view_count>46</view_count></additional><is_claimable>false</is_claimable><name>The Arrhythmogenic Calmodulin p.Phe142Leu Mutation Impairs C-domain Ca2+ Binding but Not Calmodulin-dependent Inhibition of the Cardiac Ryanodine Receptor.</name><description>A number of point mutations in the intracellular Ca&lt;sup>2+&lt;/sup>-sensing protein calmodulin (CaM) are arrhythmogenic, yet their underlying mechanisms are not clear. These mutations generally decrease Ca&lt;sup>2+&lt;/sup> binding to CaM and impair inhibition of CaM-regulated Ca&lt;sup>2+&lt;/sup> channels like the cardiac Ca&lt;sup>2+&lt;/sup> release channel (ryanodine receptor, RyR2), and it appears that attenuated CaM Ca&lt;sup>2+&lt;/sup> binding correlates with impaired CaM-dependent RyR2 inhibition. Here, we investigated the RyR2 inhibitory action of the CaM p.Phe142Leu mutation (F142L; numbered including the start-Met), which markedly reduces CaM Ca&lt;sup>2+&lt;/sup> binding. Surprisingly, CaM-F142L had little to no aberrant effect on RyR2-mediated store overload-induced Ca&lt;sup>2+&lt;/sup> release in HEK293 cells compared with CaM-WT. Furthermore, CaM-F142L enhanced CaM-dependent RyR2 inhibition at the single channel level compared with CaM-WT. This is in stark contrast to the actions of arrhythmogenic CaM mutations N54I, D96V, N98S, and D130G, which all diminish CaM-dependent RyR2 inhibition. Thermodynamic analysis showed that apoCaM-F142L converts an endothermal interaction between CaM and the CaM-binding domain (CaMBD) of RyR2 into an exothermal one. Moreover, NMR spectra revealed that the CaM-F142L-CaMBD interaction is structurally different from that of CaM-WT at low Ca&lt;sup>2+&lt;/sup> These data indicate a distinct interaction between CaM-F142L and the RyR2 CaMBD, which may explain the stronger CaM-dependent RyR2 inhibition by CaM-F142L, despite its reduced Ca&lt;sup>2+&lt;/sup> binding. Collectively, these results add to our understanding of CaM-dependent regulation of RyR2 as well as the mechanistic effects of arrhythmogenic CaM mutations. The unique properties of the CaM-F142L mutation may provide novel clues on how to suppress excessive RyR2 Ca&lt;sup>2+&lt;/sup> release by manipulating the CaM-RyR2 interaction.</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jan</publication><modification>2024-10-17T16:25:45.68Z</modification><creation>2019-03-27T02:35:05Z</creation></dates><accession>S-EPMC5270481</accession><cross_references><pubmed>27927985</pubmed><doi>10.1074/jbc.M116.766253</doi></cross_references></HashMap>